Diabetes in cystic fibrosis: Multicenter screening results based on current guidelines

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Scheuing, Nicole ^a   Holl, Reinhard W ^a   Dockter, Gerd ^b   Fink, Katharina ^a   Junge, Sibylle ^c   Naehrlich, Lutz ^d   Smaczny, Christina ^e   Staab, Doris ^f   Thalhammer, Gabriela ^g   Van Koningsbruggen Rietschel, Silke ^h   Ballmann, Manfred ⁱ  

^a UNIVERSITY OF ULM   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^e GOETHE UNIVERSITY   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUSTRIA; BODY MASS; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES; DIABETES MELLITUS; DIABETIC GLUCOSE TOLERANCE; DISEASE ASSOCIATION; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; RISK FACTOR; SCREENING; SEX DIFFERENCE; UNDERWEIGHT;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CYSTIC FIBROSIS; DEMOGRAPHY; DIABETES COMPLICATIONS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84891944213     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081545     Document Type: Article

References (30)

1. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, et al. (2009) Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 32: 1626-1631.
2. Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, et al. (2010) Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 33: 2697-2708.
3. Konrad K, Thon A, Fritsch M, Fröhlich-Reiterer E, Lilienthal E, et al. (2013) Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian pediatric diabetes registry. Diabetes Care 36: 879-886.
4. Moran A, Becker D, Casella SJ, Gottlieb PA, Kirkman MS, et al. (2010) Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care 33: 2677-2683.
5. Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, et al. (2008) Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 152: 540-545.
6. Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, et al. (2007) Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 6: 101-109. (Pubitemid 46394299)
7. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C (1995) Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 311: 655-659.
8. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiøtz PO, et al. (1994) Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 83: 72-77. (Pubitemid 24072085)
9. Buck C, Thon A, Wolf A, Kohne E, Holl RW (2000) Diagnosis of diabetes mellitus in cystic fibrosis (CF)-role of blood sugar, HbA1c and oral glucose tolerance test. Monatsschr Kinderheilkd 148: 698-701. (Pubitemid 30497862)
10. Holl RW, Buck C, Babka C, Wolf A, Thon A (2000) HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care 23: 126. (Pubitemid 30022909)
11. Widger J, Oliver MR, O'Connell M, Cameron FJ, Ranganathan S, et al. (2012) Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis. PLoS One 7: e44844.
12. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications-report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization (WHO/NCD/NCS/99.2).
13. Mueller-Brandes C, Holl RW, Nastoll M, Ballmann M (2005) New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis. Eur Respir J 25: 715-717. (Pubitemid 40528767)
14. Radike K, Molz K, Holl RW, Poeter B, Hebestreit H, et al. (2011) Prognostic relevance of hypoglycemia following an oral glucose challenge for cystic fibrosis-related diabetes. Diabetes Care 34: e43.
15. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al. (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167.
16. Rosario AS, Kurth BM, Stolzenberg H, Ellert U, Neuhauser H (2010) Body mass index percentiles for children and adolescents in Germany based on a nationally representative sample (KiGGS 2003-2006). Eur J Clin Nutr 64: 341-349.
17. Borowitz D, Baker RD, Stallings V (2002) Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 35: 246-259.
18. Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D (2004) Cystic fibrosis adult care: consensus conference report. Chest 125: 1-39.
19. World Health Organization (1980) Second report of the WHO expert committee on diabetes mellitus. Tech. Rep. Ser. No. 646. Geneva: World Health Organization.
20. Cystic Fibrosis Canada (2010) Canadian cystic fibrosis patient data registry report. Available: www.cysticfibrosis.ca/assets/files/pdf/cpdr-reporte. pdf. Accessed 2013 May 2.
21. Lanng S (2001) Glucose intolerance in cystic fibrosis patients. Paediatr Respir Rev 2: 253-259. (Pubitemid 34460746)
22. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, et al. (2005) Epidemiology of cystic fibrosis-related diabetes. J Pediatr 146: 681-687. (Pubitemid 40616255)
23. Ode KL, Frohnert B, Laguna T, Phillips J, Holme B, et al. (2010) Oral glucose tolerance testing in children with cystic fibrosis. Pediatr Diabetes 11: 487-492.
24. Cawood TJ, McKenna MJ, Gallagher CG, Smith D, Chung WY, et al. (2006) Cystic fibrosis-related diabetes in adults. Ir Med J 99: 83-86.
25. Moran A, Milla C (2003) Abnormal glucose tolerance in cystic fibrosis: why should patients be screened? J Pediatr 142: 97-99. (Pubitemid 36232893)
26. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, et al. (1999) Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 45: 61-73. (Pubitemid 29356125)
27. Bell SC, Bye PT, Cooper PJ, Martin AJ, McKay KO, et al. (2011) Cystic fibrosis in Australia, 2009: results from a data registry. Med J Aust 195: 396-400.
28. Stern M, Wiedemann B, Wenzlaff P, German Cystic Fibrosis Quality Assessment Group (2008) From registry to quality management: the German cystic fibrosis quality assessment project 1995-2006. Eur Respir J 31: 29-35.
29. American Diabetes Association (2012) Standards of medical care in diabetes-2012. Diabetes Care 35: 11-63.
30. Schmid K, Fink K, Holl RW, Hebestreit H, Ballmann M (2013) Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test. J Cyst Fibros. Doi: 10.1016/j.jcf.2013.06.001.